Newborn blood spot screening: data collection and performance analysis report

Published 1 January 2014 Last updated 18 December 2020 + show all updates 18 December 2020 Added the 2017 to 2018 data report (previously published elsewhere). 22 May 2018 Publication of data report 1 April 2016 to 31 March 2017. 13 March 2017 Added 2015 to 2016 report. 31 March 2016 2014 to 2015 data collection and performance analysis report added. 26 August 2015 Published 2013 to 2014 data report, and removed interim data update and 2013 to 2013 report. 1 January 2014 First published. Source link

0 Comments

PHE data and analysis tools

This resource is in development and will be added to over time, so let us know if you do not find the information you need or if you would like to give feedback. About this resource What it does Public Health England (PHE) provides many high quality data and analysis tools and resources for public health professionals. The PHE data and knowledge gateway provides direct access to these resources. Who it is for The resources help local government and health service professionals make decisions and plans to improve people’s health and reduce inequalities in their area. They can be used by anyone with an interest in understanding the…

0 Comments

Cost benefit analysis: health economic studies

This page is part of a guide to evaluating digital health products. Cost benefit analysis (CBA) is one economic evaluation tool to compare the costs and effects of alternative interventions. CBA measures both costs and effects of interventions in monetary terms. This usually involves placing a monetary value on health benefits. As all effects are converted to monetary values, CBA can consider non-health benefits together with health effects of the digital product. CBA studies often consider non-health benefits such as: cost savings (financial benefits) productivity gains (indirect benefits) wellbeing and convenience (intangible benefits) For example, a digital product designed to promote activity among obese people may have the…

0 Comments